This contract involves the procurement of Type II human medicines (exclusive medications) for the Hospital Universitario Doctor José Molina Orosa, under the framework agreement No. 23/S/24/SU/DG/N/AM23. The procurement is managed by the Gerencia de Servicios Sanitarios del Área de Salud de Lanzarote
Contract awarded. Originally published 5 months ago.
This contract opportunity involves the procurement of exclusive type II human medicines for the Hospital Universitario Doctor José Molina Orosa, under the Canarian Health Service. The procurement is based on the framework agreement No. 23/S/24/SU/DG/N/AM26, which allows for the supply of these speci
This contract opportunity involves the procurement of exclusive human medicines (Type II) for the Hospital Universitario Doctor José Molina Orosa, under the framework agreement No. 23/S/24/SU/DG/N/AM26. The medicines are intended for use within the Canarian Health Service. Suppliers are invited to p
This procurement contract is part of the Administrative File derived from Framework Agreement 23/S/24/SU/DG/N/AM25. It involves the supply of exclusive type II human medicines for the Canary Health Service, specifically for the Doctor José Molina Orosa University Hospital. The total value of the con
This procurement contract is part of the administrative process derived from Framework Agreement 23/S/24/SU/DG/N/AM25. It involves the supply of exclusive type II human medicines for the Canary Health Service, specifically for the Doctor José Molina Orosa University Hospital. The total value of the
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
